Author:
Chung Bong Jae,Martinez Brandon,Vaidya Ashwin
Publisher
Springer International Publishing
Reference47 articles.
1. J.L. Gayton, Etiology, prevalence, and treatment of dry eye disease. Clin. Ophthalmol. 3, 405 (2009)
2. H. Liang, C. Baudouin, P. Daull, J. Garrigue, F. Brignole-Baudouin, Effects of prostaglandin analogues anti-glaucoma therapies on ocular surface mucins. ARVO Annual Meeting Abstract (2012)
3. C.F. Cerretani, The Role of the Tear-Film Lipid Layer in Tear Dynamics and in Dry Eye. Ph.D. Dissertation, Chemical Engineering, University of California, Berkeley, 2013
4. I.K. Gipson,Y. Hori, P. Argeso, Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2(2), 131–148 (2004)
5. S.K. Lai, Y.Y. Wang, J. Hanes, Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Delivery Rev. 61(2), 158–171 (2009)